EU nod for Pfizer’s men B jab Trumenba
Pfizer’s Trumenba has been cleared by European regulators to help prevent infection with meningococcal group B disease in adolescents and adults.
Read More
Tag: Neisseria meningitidis
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
